S. Sandra, P. Misra, T.J. Lukas, J. Borensztajn, Y-J.
Zhu, B. Thimmapaya and J.K. Reddy. Northwestern
Univ., Feinberg Sch. of Med. and Dr. Reddy’s Inst. of
Life Sci., Hyderabad, India.
(257.2)
P28
miR-21 inhibition overcomes ethanol suppression of rat
liver regeneration.
E. Juskeviciute, R.P. Dippold, A.
Swarup and J.B. Hoek. Thomas Jefferson Univ. and
Univ. of Maryland Baltimore.
(257.3)
P29
Hypoxia-inducible factor-1
a activation in hepatocytes
promotes liver regeneration after acetaminophen
overdose.
B.L. Copple and J.P. Luyendyk. Michigan
State Univ.
(257.4)
P30 Acceleration of liver regeneration by betaine
supplementation via enhancement of sulfur-containing
amino acid metabolism.
C.W. Ahn, D.S. Jun and Y.C.
Kim. Seoul Natl. Univ. Col. of Pharm. (872.1)
P31
Wnt5a inhibits
b-catenin signaling and proliferation in
hepatocyte cultures: implications in liver regeneration.
J.K. Monga, S. Ravindramurthy, A. Cusimano, K.N.
Nejak-Bowen and S.P. Monga. Univ. of Pittsburgh.
(872.2)
P32
Absence of beta-catenin in liver attenuates bile duct
injury.
K.N. Nejak-Bowen, M.D. Thompson and S.P.
Monga. Univ. of Pittsburgh and Nationwide Children’s
Hosp., Columbus.
(387.3)
P33 Bile acid depletion increases susceptibility to
acetaminophen-induced hepatotoxicity in mice.
B.
Bhushan, P. Borude, G. Edwards, C. Walesky, J.
Cleveland, F. Li, X. Ma and U. Apte. Univ. of Kansas
Med. Ctr.
(387.1)
P34
Bile acids elicit production of interleukin-23 by
hepatocytes.
K.M. O’Brien and B.L. Copple.
Michigan State Univ.
(387.2)
P35
Regulation of hepatic stellate cell activation through
LRP1: a novel signaling role for t-PA in liver.
L-I.
Kang, W.C. Bowen, A. Orr, S.C. Muratoglu, D.K.
Strickland, G.K. Michalopoulos and W.M. Mars.
Univ. of Pittsburgh Sch. of Med. and Univ. of Maryland
Sch. of Med.
(387.4)
P36
Acidic sphingomyelinase inhibition limits CCl
4
-induced
hepatic fibrosis.
R.C. Quillin III, G. Wilson, H. Nojima,
J. Wang, R. Schuster, J. Blanchard, M. Edwards, E.
Gulbins and A. Lentsch. Univ. of Cincinnati. (387.5)
P37
Disfunction of endosome prevents developing alcoholic
fatty liver disease via inhibition of TLR4, TLR7, and
TLR9 signaling pathways.
H. Matsumoto, S. Okazaki
and R. Katada. Sapporo Med. Univ. Sch. of Med.
(387.6)
P38
w-3 Fatty acid effects on obese leptin knockout mice.
A. Ali, J. Nachnani, D. Bulchandani, L. Alba, A.
Mansour, H. Hamdan, T. Quinn, A. Molteni and B.
Herndon. Univ. of Missouri-Kansas City Sch. of Med.
and Sumner Med. Gp., Gallatin, TN.
(872.6)
P39
Targeting mTOR signaling for the prevention of
progenitor-derived hepatocellular carcinoma.
J.A.
Sanders, K. Brilliant, H. Francois and D. Mills.
Rhode Island Hosp. and Alpert Med. Sch., Brown
Univ.
(872.7)
P40
Glypican 3 increases IRS4 phosphorylation and
stimulates hepatocellular carcinoma cell proliferation.
E. Ganapathy, R. Khachatoorian and S.W. French.
UCLA.
(872.11)
P41
Biogenic amines secreted by cholangiocarcinoma
modulate macrophage activation.
D. Leyva-Illades
and S. DeMorrow. Texas A&M Hlth. Sci. Ctr. and
Central Texas Veterans Healthcare Syst., Temple.
(387.8)
P42
Drug-induced glutamine depletion hinders the growth
of
b-catenin mutated human liver cancer xenografts.
M. Chiu, S. Tardito, S. Pillozzi, A. Arcangeli, N.
Campanini, E.M. Silini and O. Bussolati. Univ. of
Parma and Univ. of Florence.
(387.9)
P43
Hedgehog signaling pathway regulates autophagy in
human hepatocellular carcinoma cells.
Y. Wang, C.
Han and T. Wu. Tulane Univ. Sch. of Med. and Tongji
Med. Col. Tongji Hosp., China.
(387.12)
P44
A novel in vitro three-dimensional bioprinted liver tissue
system for drug development.
J.B. Robbins, V.
Gorgen, P. Min, B.R. Shepherd and S.C. Presnell.
Organovo Inc., San Diego.
(872.12)
P45
Thy1-positive cell transplantation activates the growth
of small hepatocyte-like progenitor cells in rat livers
treated with retrorsine and PH.
T. Mitaka, N. Ichinohe,
J. Kon, N. Tanimizu, Y. Nakamura, T. Mizuguchi and
K. Hirata. Sapporo Med. Univ., Japan. (257.7)
P46
Mesenchymal stem cells from porcine bone marrow
of the os femoris and the crista iliaca.
P. Stock, S.
Brückner, H. Tautenhahn, S. Pelz, M. Hempel and
B. Christ. Univ. of Leipzig, Germany. (257.8)
P47
Effects of prototypical nuclear receptor ligands on the
expression of enzymes and transporters in primary
human hepatocytes.
A. Ullrich, M. Keiser, A. Sauer,
D. Runge, W. Siegmund and S. Oswald. PRIMACYT
Cell Culture Technol. GmbH, Schwerin and Univ.
Greifswald, Germany.
(257.9)
PATHOLOGY TUESDAY
109
T
U
E
391.
NEUROPATHOLOGY SCIENTIFIC INTEREST GROUP
POSTER DISCUSSION AND NETWORKING SESSION
Poster Discussion
(Sponsored by: ASIP Neuropathology Scientific Interest
Group)
t
ue
. 5:30
pm
—W
estin
B
oston
W
aterFront
h
otel
,
G
ranD
B
allroom
a
C
haired
: W. t
ourtellette
Neuropathology
P48
HDAC7 mediated activation of STAT3 in human PTEN
deficient glioma cells suppresses angiogenesis and
tumor growth in vivo.
A. Turtoi, A. Blomme and V.
Castronovo. Univ. of Liege, Belgium. (380.1)
P49
Expression of orphan G protein-coupled receptors
in glioblastomas.
G.R. Kolar and G.L.C. Yosten.
Washington Univ. in St. Louis and Saint Louis Univ.
(873.2)
P50
Neuregulin-1 overexpression and p53 haploinsufficiency
cooperatively promote de novo MPNST pathogenesis.
S.N. Brosius, A.N. Turk, S.J. Byer, N.M. Brossier, L.
Kohli, K.A. Roth and S.L. Carroll. Univ. of Alabama
at Birmingham.
(380.2)
P51 Comparison of genomic profiling, cytogenetics,
and histology in adult and pediatric cases of
medulloblastoma.
R. Schober, H. Holland, P. Ahnert,
D. Fritzsch, L-X. Xu, W. Krupp and J. Meixensberger.
Univ. of Leipzig, Germany.
(380.4)
P52
M-type K
+
channel openers: in vivo neuroprotective role
during cerebrovascular stroke.
S.M. Bierbower, F.
Choveau and M.S. Shapiro. Univ. of Texas Hlth. Sci.
Ctr. at San Antonio.
(873.3)
P53
IL-6 mediates impaired motor coordination but not
cognition in a murine model of mild traumatic brain
injury.
S.H. Yang, M. Gangidine, T. Pritts and A.
Lentsch. Univ. of Cincinnati. (873.4)
P54
Inflammatory cells and cytokines in the olfactory bulb
of a rat model of neuroinflammation: insights into
neurodegeneration?
M-F. Doursout, M.S. Schurdell,
L.M. Young, U. Osuagwu, D.M. Hook, B.J.
Poindexter, M.C. Schiess, D.L. Bick and R.J. Bick.
Univ. of Texas Med. Sch. at Houston.
(873.11)
P55
Depletion of PINK1 mediates mitochondrial dynamics
in chronic MPP+ toxicity.
J. Zhu, R.K. Dadga and C.
Chu. Univ. of Pittsburgh. (873.13)
P56
BNIP3 regulates AT101-induced cytotoxicity in MPNST
cells.
N. Kaza, S.L. Carroll and K.A. Roth. Univ. of
Alabama at Birmingham.
(380.3)
P57
Silencing of drpr leads to muscle and brain degeneration
in adult Drosophila.
I. Draper, L.J. Mahoney, S.
Mitsuhashi, M.R. Freeman, R.N. Salomon and P.B.
Kang. Tufts Med. Ctr., Boston Children’s Hosp. and
Univ. of Massachusetts Med. Sch.
(873.14)
P58 Stimulation of the amyloid-
b precursor protein
metabolism by cAMP.
R. Ricciarelli, E. Canepa,
C. Domenicotti, B. Marengo, E. Gardella, U.M.
Marinari, M.A. Pronzato and E. Fedele. Univ. of
Genoa.
(873.18)
P59
Egr3-dependent muscle stretch receptor morphogenesis
and innervation homeostasis.
M. Oliveira Fernandes,
K. Gruner and W.G. Tourtellotte. Northwestern Univ.
Feinberg Sch. of Med.
(380.8)
P60
Role of Elp1 in neural crest cell migration, differentiation
and target tissue innervation in familial dysautonomia.
M.Z. Jackson, K.A. Gruner and W.G. Tourtellotte.
Northwestern Univ., Chicago.
(380.5)
P61
Striatal development involves a switch in gene
expression networks, followed by a myelination event:
implications for neuropsychiatric disease.
G. Novak, T.
Fan, B.F. O’Dowd and S.R. George. Univ. of Toronto
and Ctr. for Addiction and Ment. Hlth., Toronto.
(380.6)
P62
Opioid growth factor prevents relapses in mice with
relapsing-remitting EAE, a model for multiple sclerosis.
L.A. Hammer, I.S. Zagon and P.J. McLaughlin. Penn
State Col. of Med.
(873.10)
P63
CAP37: a marker of neuroinflammation.
A.J. Brock,
A. Kasus-Jacobi, M. Lerner, A.M. Adesina and A.
Pereira. Univ. of Oklahoma Hlth. Sci. Ctr. and Baylor
Col. of Med.
(873.9)
392. VASCULAR AND MUCOSAL PATHOBIOLOGY
SCIENTIFIC INTEREST GROUP POSTER
DISCUSSION AND NETWORKING SESSION
Poster Discussion
(Sponsored by: ASIP Vascular and Mucosal Pathobiology
Scientific Interest Group)
t
ue
. 5:30
pm
—W
estin
B
oston
W
aterFront
h
otel
,
G
ranD
B
allroom
a
C
haired
: F.W. l
usCinsKas
, a. n
usrat
, D. m
ilner
, m.
s
Chnoor
anD
D. p. s
ullivan
Vascular Biology
Mucosal Pathobiology
P64 Attenuation of experimental atherosclerosis by
interleukin-19.
S. Ellison, K. Gabunia, J. Richards,
S.E. Kelemen, R.N. England, R. Scalia, A.W. Orr,
L.M. Berglund, M.F. Gomez and M.V. Autieri. Temple
Univ. Sch. of Med, LSU Hlth. Sci. Ctr., Shreveport and
Lund Univ., Sweden.
(869.7)
P65
Endothelium exposed to atheroprone flow promotes
monocyte transmigration and specification.
A.
Turjman, E.R. Edelman and G. García-Cardeña.
MIT, Brigham and Women’s Hosp. and Harvard Med.
Sch.
(379.4)
P66
Dual activation of p38MAPK and SFK pathways is
required to induce endothelial permeability.
A.P.
Adam, A. Lowery and P. Vincent. Albany Med. Col.
(379.9)
P67 Endothelial calcium signaling during leukocyte
transendothelial migration.
E. Weber, F. Han and W.A.
Muller. Northwestern Univ. Feinberg Sch. of Med.
(646.1)
P68 Severe sepsis cytomix elicits inflammation
in cerebrovascular endothelial cells and
polymorphonuclear leukocytes in vitro.
C. Blom,
B. Deller, D.D. Fraser, C. Martin, B. Young and G.
Cepinskas. Lawson Hlth. Res. Inst., London, Canada.
(868.7)
P69 ICAM1 ligation-induced transmigratory complex
formation regulates leukocyte transendothelial
migration.
M.R. Williams, S.D. Auerbach, P. Alcaide,
G. Newton and F.W. Luscinskas. Brigham and
Women’s Hosp. and Harvard Med. Sch.
(57.5)
TUESDAY PATHOLOGY
110
P70
Autocrine regulation of endothelial barrier integrity by
CAP37.
E. Fox, A. Pereira and J. Reichner. Alpert
Med. Sch. of Brown Univ./Rhode Island Hosp. and
Univ. of Oklahoma Hlth. Sci. Ctr.
(646.13)
P71
Investigating novel roles for exogenous and endogenous
galectin-3 in controlling vascular inflammation.
B.
Gittens, M. Perretti and D. Cooper. Barts and the
London Med. Sch., Queen Mary Univ. of London.
(138.12)
P72
Glutaredoxin overexpression inhibits angiogenesis in
vivo through regulation of soluble VEGFR1.
C.E.
Murdoch, M.M. Shuler, R. Kikuchi, K. Walsh, R.A.
Cohen and R. Matsui. Boston Univ. (251.1)
P73
A role for endomucin-1 in maintaining a non-
inflammatory endothelial surface and in the regulation
of leukocyte-endothelial cell interactions.
J. Yang, A.
Zahr, P. Alcaide, A. Jones, M. Gregory-Ksander,
F.W. Luscinskas, B. Ksander, P. Argueso and P.A.
D’Amore. Schepens Eye Res. Inst./Massachusetts
Eye and Ear Infirm., Harvard Med. Sch., Tufts Med.
Ctr. and Brigham and Women’s Hosp.
(57.4)
P74
Pharmacological inhibition of p38 mitogen-activated
protein kinases affects KC/CXCL1-induced
intraluminal crawling, transendothelial migration, and
chemotaxis of neutrophils in vivo.
L. Liu, M. Hossain
and S.M. Qadri. Univ. of Saskatchewan. (646.3)
P75
TNFR2 induces IRF-1 dependent IFN
b autocrine
signaling in endothelial cells to promote monocyte
recruitment.
D.A. Venkatesh, T. Ernandez, F. Rosetti,
I. Batal, X. Cullere, Y. Zhang, G. García-Cardeña, G.
Stavrakis, B. Horwitz and T.N. Mayadas. Brigham
and Womens Hosp., Harvard Med. Sch.
(57.3)
P76
Fundamental role for HIF-1
a in expression of enteric
human
b defensin-1. C.J. Kelly, L.E. Glover, E.L.
Campbell, S.F. Ehrentraut, D.J. Kominsky, B.E.
Bowers, A.J. Bayless, B.J. Saeedi and S.P. Colgan.
Univ. of Colorado Sch. of Med.
(131.7)
P77
Neutrophil-derived microparticles as novel effectors in
joint disease.
S.E. Headland, F. Dell’Accio and M.
Perretti. Barts and The London Med. Sch., Queen
Mary Univ. of London.
(137.6)
P78
Fut3-driven expression of sialyl Lewis A on intestinal
epithelium regulates PMN clearance.
J. Brazil, R.
Liu, R.D. Cummings, C.A. Parkos and N.A. Louis.
Emory Univ.
(137.7)
P79
Neutrophil interactions with apical epithelial ICAM-1
contribute to resolution of inflammation by promoting
intestinal epithelial wound repair.
R. Sumagin, P.
Nava, A. Nusrat and C.A. Parkos. Emory Univ.
(137.9)
P80
Pemphigus autoantibodies identify a desmoglein 3/
p38MAPK adhesion complex regulating keratinocyte
cohesion.
V. Spindler, C. Dehner, V. Roetzer and J.
Waschke. Ludwig Maximilians Univ., Munich. (256.6)
P81
Desmoglein 2 ectodomain regulates intestinal epithelial
cell homeostasis.
R. Kamekura, P. Nava-Dominguez,
R. Hamilton, C.A. Parkos and A. Nusrat. Emory
Univ.
(256.7)
P82
aSNAP controls b1-integrin trafficking and FAK/Src
dependent cell-matrix adhesions in human epithelial
cells.
N.G. Naydenov, A. Feygin and A.I. Ivanov.
Virginia Commonwealth Univ.
(132.5)
P83
The N-formyl peptide receptor 1 is required for enteric
commensal mediated mucosal homeostasis and
restitution.
A. Alam, G. Leoni, C. Wentworth, J. Kwal,
R. Jones, C. Ardita, P. Swanson II, A. Nusrat and A.
Neish. Emory Univ. Sch. of Med. (132.8)
P84
Salmonella typhimurium directs the localization of the
desmosomal protein, PERP, to induce inflammation.
K. Hallstrom, J.E. Casanova and B.A. McCormick.
Univ. of Massachusetts Med. Sch. and Univ. of Virginia
Hlth. Syst.
(131.6)
393. VETERINARY PATHOLOGY SCIENTIFIC
INTEREST GROUP POSTER DISCUSSION AND
NETWORKING SESSION
Poster Discussion
(Sponsored by: ASIP Veterinary Pathology Scientific
Interest Group)
t
ue
. 5:30
pm
—W
estin
B
oston
W
aterFront
h
otel
,
G
ranD
B
allroom
a
C
haired
: e. W
hitley
Veterinary Pathology
P85
Exploring phospho-signaling pathways in patients with
age-related macular degeneration, human pigment
epithelial cell line ARPE-19 and porcine ocular tissue.
E. Fasler-Kan, N. Barteneva and P. Meyer. Inst. of
Chem. and Bioanalyt., Muttenz, Switzerland, Immune
Dis. Inst., Boston and Univ. of Basel.
(645.11)
P86
An interleukin-15 fusion protein enhances the oncolytic
effects of myxoma virus in a murine melanoma
model.
A.L. MacNeill, V. Tosic, R.A. Doty, J. Liu, G.
McFadden and E.J. Roy. Univ. of Illinois, Urbana and
Univ. of Florida.
(1087.13)
P87
The effects of corn and soybean grain dusts on the
asthmatic phenotype using a murine model of fungal
allergic asthma.
A. Sharma, S.A. Hoselton, S. Ghosh
and J.M. Schuh. North Dakota State Univ. (648.6)
P88
Disparate features of allergic airway disease between
young and old mice.
C. Brandenberger, D.N.
Jackson-Humbles, K.M. Allen, J.G. Wagner, N. Li
and J.R. Harkema. Michigan State Univ. (648.12)
P89
Stimulating innate immunity in feedlot cattle: strategies
to induce tracheal antimicrobial peptide gene
expression.
L.M. Berghuis, J. Caswell, S. Sharif and
N. Karrow. Univ. of Guelph, Canada. (649.8)
P90
Pathophysiologic and metabolomic analyses in a model
for closed abdomen septic swine treated with negative
pressure therapy.
K.C. Norbury. Kinetic Concepts
Inc., San Antonio.
(868.2)
P91
Equine navicular syndrome: historical, pathological
and biomechanical insights into pathogenesis and
treatment.
E.W. Uhl and J.L. Cornille. Univ. of
Georgia and Sci. of Motion, Datonton, GA.
(874.4)
P92
Glycogen storage disease II in Lapland dogs.
K.J.
Dillard, K. Vainio-Siukola, G. Vidgren and M.
Anttila. Evira, Helsinki. (874.10)
PATHOLOGY TUESDAY
111
T
U
E
P93
Necropsy: useful tool to study the life habits and the
parasitism by Dioctophyme renale in maned wolf
(Chrysocyonbrachyurus), Brazil.
J. Duarte, C.M.
Ribeiro, V.C.C. Hyodo, A.M.B. Costa, J.A. Martins
and M.E. Oliveira. Univ. Paulista, San Jose dos
Campos and Fatec, Jacarei, Brazil.
(874.11)
P94 Immunohistochemical localization of arginase-1
expression in B6 and BALB/c mice.
D.K. Meyerholz.
Univ. of Iowa Carver Col. of Med.
(874.6)
P95
Spontaneous salivary gland carcinomas in GON4l
deficient mice.
K.N. Gibson-Corley, A.L. Simons,
Dostları ilə paylaş: |